1. Accelerated access to innovative medicines for patients in need;Baird;Clin Pharmacol Ther,2014
2. FDA facilitated regulatory pathways: visualizing their characteristics, development, and authorization timelines;Liberti;Front Pharmacol,2017
3. Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe;Boon;Clin Pharmacol Ther,2010
4. Health Canada. (2020). Guidance Document: notice of compliance with conditions (NOC/C). Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/notice-compliance-conditions.html#a2.3.
5. European Medicines Agency. (2006). Commission regulation (EC) No 507/2006. Available from: https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/conditional-marketing-authorisation.